Urinary Proteomics and Sepsis-Associated Acute Kidney Injury
Author Information
Author(s): Stanaway Ian B., Morrell Eric D., Mabrey F. Linzee, Sathe Neha A., Bailey Zoie, Speckmaier Sarah, Lo Jordan, Zelnick Leila R., Himmelfarb Jonathan, Mikacenic Carmen, Evans Laura, Wurfel Mark M., Bhatraju Pavan K.
Primary Institution: University of Washington
Hypothesis
The study aims to understand the biological differences between two sub-phenotypes of acute kidney injury (AKI) associated with sepsis.
Conclusion
The study identifies distinct immunological profiles between AKI sub-phenotypes, suggesting potential therapeutic targets.
Supporting Evidence
- 117 urine proteins were higher in AKI-SP2, while 195 were higher in AKI-SP1.
- Pathways related to immune response were upregulated in AKI-SP2.
- Patients with AKI-SP2 had a higher risk of renal replacement therapy.
Takeaway
Doctors found that patients with sepsis can have different types of kidney problems, and studying their urine can help understand these differences better.
Methodology
The study enrolled 173 ICU patients with sepsis, classified them into AKI sub-phenotypes, and analyzed urinary proteins using aptamer-based proteomics.
Potential Biases
Potential probe cross-reactivity and nonspecific binding in aptamer-based proteomic methods.
Limitations
The AKI-SP2 population is small, and urine output data was missing for some patients.
Participant Demographics
Mean age 53 years, 61% men, 57% White, 17% Black, 12% Asian, 21% LatinX.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.69–0.99
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website